[go: up one dir, main page]

CY1112118T1 - 3-ινδαζολυλ-4-πυριδυλισοθειαζολες - Google Patents

3-ινδαζολυλ-4-πυριδυλισοθειαζολες

Info

Publication number
CY1112118T1
CY1112118T1 CY20111101158T CY111101158T CY1112118T1 CY 1112118 T1 CY1112118 T1 CY 1112118T1 CY 20111101158 T CY20111101158 T CY 20111101158T CY 111101158 T CY111101158 T CY 111101158T CY 1112118 T1 CY1112118 T1 CY 1112118T1
Authority
CY
Cyprus
Prior art keywords
indazolyl
pyridylisothiazoles
isothiazoles
pyridyl
intermediates
Prior art date
Application number
CY20111101158T
Other languages
English (en)
Inventor
Thomas Charles Britton
Veronique Dehlinger
Adam Michael Fivush
Sean Patrick Hollinshead
Benjamin Paul Vokits
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1112118T1 publication Critical patent/CY1112118T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση προσφέρει 3-ινδαζολυλ-4-πυριδυλ-ισοθειαζόλες με τον ακόλουθο τύπο ή ένα φαρμακευτικά αποδεκτό άλας αυτών, φαρμακευτικές συνθέσεις αυτών, και μεθόδους χρήσης τους, καθώς και διαδικασίες για την παρασκευή τους και τις ενδιάμεσες αυτών.
CY20111101158T 2008-04-04 2011-11-25 3-ινδαζολυλ-4-πυριδυλισοθειαζολες CY1112118T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4239408P 2008-04-04 2008-04-04
EP09727170A EP2276759B1 (en) 2008-04-04 2009-03-18 3-indazolyl-4-pyridylisothiazoles

Publications (1)

Publication Number Publication Date
CY1112118T1 true CY1112118T1 (el) 2015-11-04

Family

ID=40725748

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101158T CY1112118T1 (el) 2008-04-04 2011-11-25 3-ινδαζολυλ-4-πυριδυλισοθειαζολες

Country Status (24)

Country Link
US (1) US7932274B2 (el)
EP (1) EP2276759B1 (el)
JP (1) JP5449320B2 (el)
KR (1) KR101247010B1 (el)
CN (1) CN101959883B (el)
AR (1) AR070986A1 (el)
AT (1) ATE529422T1 (el)
AU (1) AU2009232263B2 (el)
BR (1) BRPI0910692A2 (el)
CA (1) CA2720631C (el)
CL (1) CL2009000646A1 (el)
CY (1) CY1112118T1 (el)
DK (1) DK2276759T3 (el)
EA (1) EA018001B1 (el)
ES (1) ES2372677T3 (el)
HR (1) HRP20110784T1 (el)
JO (1) JO2775B1 (el)
MX (1) MX2010010781A (el)
PE (1) PE20091681A1 (el)
PL (1) PL2276759T3 (el)
PT (1) PT2276759E (el)
SI (1) SI2276759T1 (el)
TW (1) TW200944522A (el)
WO (1) WO2009123855A1 (el)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075001A (en) 1976-06-18 1978-02-21 Fmc Corporation 3-Aminoisothiazole derivatives as herbicides
IL72091A0 (en) 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) 1993-08-24 1995-03-02 Basf Ag Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
ES2249920T3 (es) 1998-10-23 2006-04-01 Dow Agrosciences Llc Compuestos de 3.(fenilo sustituido)-5-(heterociclilo sustituidoi-1,2,4-triazol.
DE60205974T2 (de) * 2001-04-04 2006-06-29 Pfizer Products Inc., Groton Neue Benzotriazole mit entzündungshemmender Wirkung
JP2006522164A (ja) 2003-04-03 2006-09-28 メルク　エンド　カムパニー　インコーポレーテッド 代謝調節型グルタミン酸受容体−５のジアリール置換ピラゾール修飾因子
TW200735866A (en) * 2005-11-18 2007-10-01 Synta Pharmaceuticals Corp Compounds for the treatment of proliferative disorders
BRPI0712862A2 (pt) 2006-06-08 2012-12-18 Lilly Co Eli carboxamidas substituìdas
NZ579595A (en) * 2007-04-19 2012-06-29 Glaxo Group Ltd Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists

Also Published As

Publication number Publication date
CA2720631A1 (en) 2009-10-08
ATE529422T1 (de) 2011-11-15
EA018001B1 (ru) 2013-04-30
AR070986A1 (es) 2010-05-19
PE20091681A1 (es) 2009-11-04
US7932274B2 (en) 2011-04-26
AU2009232263B2 (en) 2013-07-04
CL2009000646A1 (es) 2010-04-09
CA2720631C (en) 2012-08-28
EA201071168A1 (ru) 2011-04-29
US20090253750A1 (en) 2009-10-08
JO2775B1 (en) 2014-03-15
MX2010010781A (es) 2010-12-14
JP5449320B2 (ja) 2014-03-19
HRP20110784T1 (hr) 2011-11-30
DK2276759T3 (da) 2012-01-02
JP2011516481A (ja) 2011-05-26
EP2276759A1 (en) 2011-01-26
CN101959883B (zh) 2013-01-30
SI2276759T1 (sl) 2012-02-29
TW200944522A (en) 2009-11-01
PT2276759E (pt) 2011-12-19
BRPI0910692A2 (pt) 2018-03-27
KR101247010B1 (ko) 2013-03-26
EP2276759B1 (en) 2011-10-19
CN101959883A (zh) 2011-01-26
WO2009123855A1 (en) 2009-10-08
ES2372677T3 (es) 2012-01-25
AU2009232263A1 (en) 2009-10-08
PL2276759T3 (pl) 2012-03-30
KR20100118999A (ko) 2010-11-08

Similar Documents

Publication Publication Date Title
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201070786A1 (ru) Бензофуропиримидиноны
CY1112558T1 (el) Ενωσεις ν-μεθυλαμινομεθυλο ισοϊνδολης και συνθεσεις που τις περιλαμβανουν και μεθοδοι χρησης τους
CY1118231T1 (el) Συνθεση λιποσωματος
CR11861A (es) Compuestos organicos
CY1119684T1 (el) Αντι-ιικες ενωσεις
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
CY1117143T1 (el) Νεα καρβονυλιωμενα (αζα)κυκλοεξανια ως προσδετες του d3 υποδοχεα ντοπαμινης
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
CY1115043T1 (el) Φαρμακευτικο σκευασμα
MX2010009646A (es) Agentes terapeuticos antivirales.
CY1119361T1 (el) 3,4-διυδροισοκινολιν-2(1h)-υλικες ενωσεις
EA201170227A1 (ru) Имидазолкарбоксамиды
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
CO6480927A2 (es) Derivados de imidazolin-2-ona 1,3-disustituida como inhibidores de cyp17.
CR11819A (es) Compuestos de isoindolina 5-sustituidos
EA201170872A1 (ru) Ингибиторы протеинкиназы
EA201001724A1 (ru) Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
EA201170441A1 (ru) Терапевтические противовирусные пептиды
CY1121999T1 (el) Φαρμακοτεχνικες μορφες συνδυασμου δαρουναβιρης
MX390264B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
EA201190293A1 (ru) Пролекарства триптолида
CY1119446T1 (el) Φαρμακοτεχνικες μορφες δαρουναβιρης
CY1113240T1 (el) Αλατα ενωσεων αναστολεα hiv